Search Results for: GENE CELL THERAPY Its Growing

Articles

March 18, 2013

Ligand Signs Global License Deal With Spectrum March 18, 2013

Ligand Pharmaceuticals Incorporated recently announced the signing of global license and supply agreements with Spectrum Pharmaceuticals, Inc. for the development...
March 12, 2013

DELIVERY DEVICES - The New Industry Paradigm for Prefilled Success March 12, 2013

Alan Shortall indicates that following a period of relative industry stability defined by peripheral innovation, a converging series of external and internal forces are set to reshape the prefilled syringe industry so that it will better serve the emerging needs of pharmaceutical companies, patients, and other stakeholders across the continuum of care.

February 11, 2013

2/13/2013 February 11, 2013

Frost & Sullivan Sees Urgent Need for Cancer Diagnostics Tests; Finds Unmet Need for Key Disorders The range of potential...
January 14, 2013

1/16/2013 January 14, 2013

BIND Biosciences & Amgen Sign Worldwide Development & Commercialization  Agreement BIND Biosciences recently announced it has entered into a global...
January 3, 2013

1/9/2013 January 3, 2013

Ultragenyx Secures $75 Million for Ultra-Rare Diseases Ultragenyx Pharmaceutical Inc. recently announced the successful completion of a $75-million Series B...
December 20, 2012

12/27/2012 December 20, 2012

Radius & 3M Announce Exclusive Agreement Radius Health, Inc. and 3M Drug Delivery Systems recently announced an exclusive partnership agreement...
December 13, 2012

12/19/2012 December 13, 2012

Biogen Idec & Eisai Inc. Form Strategic Alliance Biogen Idec and Eisai Inc. recently announced a strategic alliance that will...
November 26, 2012

11/28/2012 November 26, 2012

CoreRx & ViroPro Announce Agreement CoreRx, Inc. and Viropro, Inc. recently announced the two companies have entered into a Reciprocal...
November 19, 2012

11/21/2012 November 19, 2012

Innovative Drugs to Transform Alzheimer's Disease Medication Market The patent expiry of all four existing EMEA-approved drugs for Alzheimer's disease...
November 8, 2012

11/14/2012 November 8, 2012

A Note to The Pharmaceutical Industry Upon The Re-Election of Barack Obama By: Matthew Herper, Forbes Staff, mherper@forbes.com I've covered...
October 25, 2012

10/30/2012 October 25, 2012

Arthritis Signifies a Vast Untouched Market, Finds Frost & Sullivan Tumor necrosis factor (TNF) inhibitors are currently the only therapeutic...
October 21, 2012

10/24/2012 October 21, 2012

Avantor & Rubicon to Collaborate on Next-Generation Functional Excipients   Avantor Performance Materials recently announced it has signed a collaboration...
October 11, 2012

10/16/2012 October 11, 2012

Catalent Licenses Innovative Technology Following a successful research collaboration, Catalent Pharma Solutions recently announced it has taken an exclusive license...
August 26, 2012

8/29/2012 August 26, 2012

Synergy Pharmaceuticals Acquires BMS Drug Synergy Pharmaceuticals Inc. recently announced it has signed an Asset Purchase Agreement with Bristol-Myers Squibb...
August 12, 2012

8/15/2012 August 12, 2012

Quintiles Acquires Company to Advance Personalized Medicine Quintiles recently announced the acquisition of Expression Analysis, Inc. (EA), a premier provider...
August 5, 2012

8/8/2012 August 5, 2012

Researchers Discover New Mechanism Behind Resistance to Cancer Treatment Developing resistance to chemotherapy is a nearly universal, ultimately lethal consequence...
June 25, 2012

6/27/2012 June 25, 2012

Hovione Reports Significant Sales Growth Hovione recently announced that the consolidated sales for the fiscal year ended March 2012 amounted...
June 11, 2012

6/13/2012 June 11, 2012

Particle Sciences Expands cGMP Capabilities With Addition of Thin Films Particle Sciences recently announced it has added new coating capabilities...
June 4, 2012

6/6/2012 June 4, 2012

Royer Biomedical Receives Approval to Test Polymer Delivery System Royer Biomedical, Inc. (RBI) recently announced it received FDA approval to...